CMS to Launch Medicare GLP-1 Bridge Program at $50 Monthly Cost

The Centers for Medicare & Medicaid Services said it will provide eligible Medicare Part D enrollees access to certain GLP-1 weight-loss drugs at $50 a month starting July 1, 2026 through Dec. 31, 2027.

• Operates as a time-limited demonstration under the HHS secretary’s authority to test new care delivery approaches
• CMS to handle handle centralized claims adjudication and pharmacy payments

To view the source of this information, click here

© 2026 Bloomberg L.P. All rights reserved. Used with permission.